Delta 9 Cannabis (NINE) has notable insider buying
Delta 9 Cannabis (C:NINE)
![](https://m.canadianinsider.com/sites/default/files/home/company_profile_top_NINE1541415610.jpg)
![](https://m.canadianinsider.com/sites/default/files/home/company_volume_bottom_NINE1541415610.jpg)
Updated Monday Nov 05, 2018 01:43 AM EDT
John William (John) Arbuthnot IV, a Senior Officer, Director and 10% Holder executive, acquired 25,000 Common Shares on a direct ownership basis at prices ranging from $1.530 and $1.540 through the public market on October 31st, 2018. This represents a $38,486 investment into the company's shares and an account share holdings change of 0.1%.Delta 9 Cannabis Inc , formerly SVT Capital Corp, is a Canada-based company engaged in Biotechnology & Medical Research. The principal activities of The Company are the production, storage and sale of medical marijuana.
Headlines: Nov 05, 2018
DN Insider Holdings Chart
![](https://m.canadianinsider.com/sites/default/files/home/pct_chart_3353.40507407821541394000.jpg)
Issuer details as of Nov 05, 2018 1:43 ET
Latest Price
1.53
1 Day Change
-2.55%
52 Week High
4
52 Week Low
1.04
QMV ($Mils)
131,100,007
Issuer website: https://www.delta9.ca/